Profen and Debility - a phase IV clinical study of FDA data
Summary:
We study 245,545 people who take Profen (ibuprofen) or have Debility. No report of Debility is found in people who take Profen.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Profen?
Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,308 Profen users. Check the latest studies of Profen.
What is Debility?
Debility (physical weakness) is found to be associated with 6 drugs and 24 conditions by eHealthMe. Check the latest studies of Debility.
No report is found.
Do you take Profen and have Debility?
- Check whether Debility is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Profen:
- Profen (245,308 reports)
Debility treatments and more:
- Debility (237 reports)
How severe was Debility and when was it recovered:
Expand to all the drugs that have ingredients of ibuprofen:
- Debility and drugs with ingredients of ibuprofen (1 reports)
Browse all side effects of Profen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Debility:
Browse all the conditions that are associated with Debility:
How the study uses the data?
The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Profen) and Profen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Thalidomide and Hepatocellular Injury for Women aged 60+ - 2 seconds ago
- Temazepam and Injection Site Discomfort for Women aged 60+ - 6 seconds ago
- Could Wellbutrin cause Rebound Effect? - 22 seconds ago
- Topamax and Orthostatic Hypotension for Women aged 50-59 - 31 seconds ago
- Levothroid and Back Pain for Men aged 60+ - 32 seconds ago
- Levothroid and Nonspecific Back Pain for Men aged 60+ - 32 seconds ago
- Levothroid and Pain - Back for Men aged 60+ - 32 seconds ago
- Levothroid and Back Pain - Nonspecific for Men aged 60+ - 33 seconds ago
- Rubraca and Insomnia for Women aged 60+ - 35 seconds ago
- Rubraca and Can'T Sleep for Women aged 60+ - 36 seconds ago